Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Migraine Disorders | 32 | 2018 | 67 | 5.790 |
Why?
|
| Headache | 34 | 2017 | 75 | 5.010 |
Why?
|
| Behavior Therapy | 18 | 2015 | 103 | 3.280 |
Why?
|
| Tension-Type Headache | 12 | 2015 | 14 | 2.590 |
Why?
|
| Headache Disorders | 14 | 2012 | 17 | 1.990 |
Why?
|
| Stress, Psychological | 12 | 2017 | 221 | 1.420 |
Why?
|
| Biofeedback, Psychology | 9 | 2015 | 10 | 1.280 |
Why?
|
| Research Design | 12 | 2013 | 313 | 1.180 |
Why?
|
| Mental Disorders | 9 | 2009 | 121 | 1.140 |
Why?
|
| Humans | 87 | 2020 | 32006 | 0.840 |
Why?
|
| Exercise | 4 | 2017 | 672 | 0.760 |
Why?
|
| Biomedical Research | 4 | 2018 | 156 | 0.740 |
Why?
|
| Headache Disorders, Primary | 2 | 2009 | 3 | 0.630 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 881 | 0.580 |
Why?
|
| Pain | 4 | 2012 | 288 | 0.550 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 167 | 0.540 |
Why?
|
| Back Pain | 4 | 2020 | 28 | 0.520 |
Why?
|
| Relaxation Therapy | 6 | 2015 | 13 | 0.470 |
Why?
|
| Clinical Trials as Topic | 4 | 2005 | 301 | 0.460 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2019 | 510 | 0.460 |
Why?
|
| Models, Biological | 1 | 2015 | 392 | 0.440 |
Why?
|
| Exercise Therapy | 1 | 2015 | 270 | 0.430 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 91 | 0.400 |
Why?
|
| Chronic Disease | 11 | 2010 | 406 | 0.380 |
Why?
|
| Anxiety Disorders | 3 | 2008 | 77 | 0.380 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 74 | 0.350 |
Why?
|
| Research | 5 | 2005 | 74 | 0.350 |
Why?
|
| Models, Theoretical | 3 | 2017 | 137 | 0.330 |
Why?
|
| Adult | 32 | 2019 | 9346 | 0.320 |
Why?
|
| Depressive Disorder | 2 | 2008 | 75 | 0.310 |
Why?
|
| Comorbidity | 6 | 2012 | 566 | 0.300 |
Why?
|
| Manipulation, Osteopathic | 1 | 2007 | 1 | 0.290 |
Why?
|
| Relaxation | 1 | 2007 | 9 | 0.290 |
Why?
|
| Sleep | 1 | 2008 | 92 | 0.290 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2007 | 24 | 0.290 |
Why?
|
| Patient Selection | 2 | 2005 | 276 | 0.280 |
Why?
|
| Double-Blind Method | 2 | 2005 | 525 | 0.270 |
Why?
|
| Sexuality | 1 | 2006 | 9 | 0.270 |
Why?
|
| Pain Measurement | 6 | 2019 | 350 | 0.260 |
Why?
|
| Practice Guidelines as Topic | 2 | 2006 | 407 | 0.260 |
Why?
|
| Neuropsychology | 1 | 2005 | 3 | 0.250 |
Why?
|
| Sexual Behavior | 1 | 2006 | 108 | 0.250 |
Why?
|
| Middle Aged | 26 | 2019 | 11818 | 0.250 |
Why?
|
| Neuropsychological Tests | 2 | 2005 | 371 | 0.250 |
Why?
|
| Psychotherapy | 3 | 2019 | 19 | 0.240 |
Why?
|
| Female | 32 | 2019 | 19960 | 0.240 |
Why?
|
| Cognition | 2 | 2008 | 555 | 0.240 |
Why?
|
| Adolescent | 12 | 2017 | 3539 | 0.240 |
Why?
|
| Chest Pain | 1 | 2007 | 208 | 0.240 |
Why?
|
| Male | 30 | 2019 | 19166 | 0.230 |
Why?
|
| Electroencephalography | 1 | 2003 | 73 | 0.210 |
Why?
|
| Psychotherapy, Group | 1 | 2002 | 17 | 0.210 |
Why?
|
| Placebos | 1 | 2002 | 63 | 0.200 |
Why?
|
| Caffeine | 1 | 2002 | 29 | 0.200 |
Why?
|
| Treatment Outcome | 8 | 2020 | 3306 | 0.200 |
Why?
|
| Disease Progression | 4 | 2017 | 594 | 0.200 |
Why?
|
| Central Nervous System Stimulants | 1 | 2002 | 76 | 0.190 |
Why?
|
| Recurrence | 8 | 2005 | 263 | 0.190 |
Why?
|
| Telemedicine | 2 | 2019 | 102 | 0.180 |
Why?
|
| Low Back Pain | 1 | 2020 | 45 | 0.170 |
Why?
|
| Patient Compliance | 3 | 2006 | 225 | 0.170 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 876 | 0.170 |
Why?
|
| Cluster Analysis | 2 | 1999 | 125 | 0.170 |
Why?
|
| Nurses | 1 | 2019 | 15 | 0.170 |
Why?
|
| Bioethics | 1 | 2018 | 2 | 0.160 |
Why?
|
| Authorship | 1 | 2018 | 9 | 0.160 |
Why?
|
| Publications | 1 | 2018 | 9 | 0.160 |
Why?
|
| Minority Groups | 1 | 2018 | 78 | 0.150 |
Why?
|
| Poverty | 1 | 2018 | 111 | 0.150 |
Why?
|
| Health Personnel | 1 | 2019 | 121 | 0.150 |
Why?
|
| Telephone | 1 | 2018 | 59 | 0.150 |
Why?
|
| Adaptation, Psychological | 2 | 2014 | 138 | 0.140 |
Why?
|
| Remission Induction | 2 | 2013 | 84 | 0.140 |
Why?
|
| Population Surveillance | 2 | 2017 | 124 | 0.140 |
Why?
|
| Risk Factors | 7 | 2013 | 3876 | 0.130 |
Why?
|
| Secondary Prevention | 2 | 2009 | 63 | 0.130 |
Why?
|
| Meta-Analysis as Topic | 4 | 2005 | 43 | 0.130 |
Why?
|
| Aged | 11 | 2019 | 10302 | 0.130 |
Why?
|
| Depression | 4 | 2019 | 444 | 0.130 |
Why?
|
| Analysis of Variance | 3 | 2005 | 463 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2013 | 767 | 0.120 |
Why?
|
| Young Adult | 4 | 2017 | 2636 | 0.120 |
Why?
|
| Prevalence | 3 | 2013 | 981 | 0.120 |
Why?
|
| Socioenvironmental Therapy | 1 | 1994 | 1 | 0.120 |
Why?
|
| Propranolol | 2 | 1991 | 16 | 0.120 |
Why?
|
| Thinking | 1 | 2013 | 6 | 0.110 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 43 | 0.110 |
Why?
|
| Precipitating Factors | 1 | 2013 | 2 | 0.110 |
Why?
|
| Complementary Therapies | 1 | 2014 | 80 | 0.110 |
Why?
|
| Data Collection | 1 | 2013 | 180 | 0.110 |
Why?
|
| Feeding Behavior | 1 | 2013 | 161 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2012 | 191 | 0.100 |
Why?
|
| Age Distribution | 1 | 2012 | 206 | 0.100 |
Why?
|
| United States | 2 | 2018 | 3939 | 0.100 |
Why?
|
| Forecasting | 2 | 2017 | 143 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2012 | 105 | 0.090 |
Why?
|
| Muscle Contraction | 3 | 2008 | 114 | 0.090 |
Why?
|
| Health Expenditures | 1 | 2011 | 66 | 0.090 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2010 | 6 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 1531 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 1990 | 55 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2011 | 185 | 0.090 |
Why?
|
| Analgesics | 1 | 2011 | 109 | 0.090 |
Why?
|
| Home Nursing | 1 | 2009 | 10 | 0.080 |
Why?
|
| Anxiety | 2 | 2009 | 191 | 0.080 |
Why?
|
| Electromyography | 2 | 2008 | 59 | 0.080 |
Why?
|
| North Carolina | 1 | 2012 | 1514 | 0.080 |
Why?
|
| Persuasive Communication | 1 | 2007 | 4 | 0.070 |
Why?
|
| Truth Disclosure | 1 | 2007 | 13 | 0.070 |
Why?
|
| Delivery of Health Care | 2 | 2007 | 160 | 0.070 |
Why?
|
| Personality Inventory | 3 | 2003 | 18 | 0.070 |
Why?
|
| Heart Rate | 3 | 1985 | 335 | 0.070 |
Why?
|
| Pituitary-Adrenal System | 1 | 2006 | 21 | 0.070 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2006 | 31 | 0.070 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2006 | 27 | 0.070 |
Why?
|
| Serotonin | 1 | 2006 | 37 | 0.070 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2006 | 54 | 0.070 |
Why?
|
| Hormones | 1 | 2005 | 22 | 0.060 |
Why?
|
| Menstrual Cycle | 1 | 2005 | 61 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2005 | 55 | 0.060 |
Why?
|
| Physician-Patient Relations | 1 | 2007 | 185 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2006 | 173 | 0.060 |
Why?
|
| Psychological Tests | 1 | 1985 | 35 | 0.060 |
Why?
|
| Arousal | 2 | 1994 | 19 | 0.060 |
Why?
|
| Time Factors | 5 | 2013 | 2149 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2005 | 72 | 0.060 |
Why?
|
| Photophobia | 2 | 2005 | 2 | 0.060 |
Why?
|
| Coronary Disease | 2 | 1996 | 211 | 0.060 |
Why?
|
| Nausea | 2 | 2005 | 53 | 0.060 |
Why?
|
| Motor Activity | 1 | 2006 | 325 | 0.060 |
Why?
|
| Periodicity | 1 | 2002 | 11 | 0.050 |
Why?
|
| Animals | 3 | 2010 | 7541 | 0.050 |
Why?
|
| Disability Evaluation | 2 | 2019 | 240 | 0.050 |
Why?
|
| Women's Health | 2 | 2002 | 235 | 0.050 |
Why?
|
| Lead Poisoning | 1 | 1982 | 3 | 0.050 |
Why?
|
| Saliva | 1 | 2002 | 36 | 0.050 |
Why?
|
| Affect | 1 | 2002 | 69 | 0.050 |
Why?
|
| Hand | 1 | 2002 | 66 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2005 | 385 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2002 | 70 | 0.050 |
Why?
|
| Diagnosis-Related Groups | 1 | 2001 | 11 | 0.050 |
Why?
|
| Reaction Time | 1 | 2002 | 117 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2002 | 99 | 0.050 |
Why?
|
| Learning | 1 | 1982 | 79 | 0.050 |
Why?
|
| Psychometrics | 2 | 1996 | 137 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 271 | 0.050 |
Why?
|
| Desipramine | 1 | 2020 | 5 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2017 | 1817 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 633 | 0.040 |
Why?
|
| Societies, Medical | 2 | 1999 | 163 | 0.040 |
Why?
|
| Self Care | 2 | 2006 | 144 | 0.040 |
Why?
|
| Hyperacusis | 1 | 1999 | 1 | 0.040 |
Why?
|
| Vomiting | 1 | 1999 | 24 | 0.040 |
Why?
|
| Scientific Misconduct | 1 | 2018 | 4 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 1328 | 0.040 |
Why?
|
| Conflict of Interest | 1 | 2018 | 35 | 0.040 |
Why?
|
| Awareness | 1 | 2018 | 29 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 1999 | 264 | 0.040 |
Why?
|
| Sick Role | 2 | 1996 | 7 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2018 | 203 | 0.040 |
Why?
|
| Progesterone | 2 | 2002 | 101 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2002 | 845 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 582 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2017 | 93 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2001 | 53 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 257 | 0.030 |
Why?
|
| Child | 1 | 2003 | 2438 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 240 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2019 | 333 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2017 | 162 | 0.030 |
Why?
|
| Overweight | 1 | 2017 | 280 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2012 | 3509 | 0.030 |
Why?
|
| International Cooperation | 2 | 2012 | 28 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1994 | 22 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 355 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 2002 | 517 | 0.030 |
Why?
|
| Probability | 1 | 2013 | 158 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 2265 | 0.030 |
Why?
|
| Menstruation Disturbances | 1 | 1992 | 3 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2013 | 483 | 0.030 |
Why?
|
| Parturition | 1 | 2012 | 10 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2012 | 33 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 130 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 684 | 0.020 |
Why?
|
| Poloxalene | 1 | 2011 | 1 | 0.020 |
Why?
|
| Estradiol | 1 | 1992 | 136 | 0.020 |
Why?
|
| Drug Costs | 1 | 2011 | 47 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 1992 | 128 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 99 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 560 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 1990 | 28 | 0.020 |
Why?
|
| Ergotamine | 1 | 1989 | 1 | 0.020 |
Why?
|
| Obesity | 1 | 2017 | 1175 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 781 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2005 | 297 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 997 | 0.020 |
Why?
|
| Internal-External Control | 2 | 1985 | 17 | 0.020 |
Why?
|
| Headache Disorders, Secondary | 1 | 2007 | 2 | 0.020 |
Why?
|
| Treatment Refusal | 1 | 2007 | 11 | 0.020 |
Why?
|
| Sex Factors | 2 | 2002 | 663 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 1996 | 762 | 0.020 |
Why?
|
| Smoking | 1 | 1991 | 497 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2006 | 22 | 0.020 |
Why?
|
| Reminder Systems | 1 | 2006 | 22 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2006 | 78 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2006 | 185 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2005 | 22 | 0.020 |
Why?
|
| Environment | 1 | 1985 | 54 | 0.020 |
Why?
|
| Personality Disorders | 1 | 2005 | 5 | 0.020 |
Why?
|
| Prognosis | 2 | 2005 | 1497 | 0.020 |
Why?
|
| Sample Size | 1 | 2005 | 38 | 0.020 |
Why?
|
| Observation | 1 | 2005 | 25 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 217 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2005 | 71 | 0.020 |
Why?
|
| Medical Records | 1 | 2005 | 76 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2005 | 108 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2005 | 175 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1982 | 31 | 0.010 |
Why?
|
| Locomotion | 1 | 1982 | 31 | 0.010 |
Why?
|
| Prejudice | 1 | 2002 | 50 | 0.010 |
Why?
|
| Pain Clinics | 1 | 2001 | 1 | 0.010 |
Why?
|
| Migraine without Aura | 1 | 2001 | 1 | 0.010 |
Why?
|
| Migraine with Aura | 1 | 2001 | 2 | 0.010 |
Why?
|
| Social Class | 1 | 2002 | 89 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2001 | 49 | 0.010 |
Why?
|
| Age of Onset | 1 | 2001 | 94 | 0.010 |
Why?
|
| Estrogens | 1 | 2002 | 180 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2002 | 241 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 2282 | 0.010 |
Why?
|
| Vascular Headaches | 1 | 1998 | 1 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1982 | 605 | 0.010 |
Why?
|
| Rats | 1 | 1982 | 1595 | 0.010 |
Why?
|
| Type A Personality | 1 | 1996 | 1 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1996 | 44 | 0.010 |
Why?
|
| Continental Population Groups | 1 | 1998 | 237 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1996 | 97 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 1994 | 77 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1994 | 103 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2001 | 3990 | 0.010 |
Why?
|
| Software Validation | 1 | 1992 | 4 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 44 | 0.010 |
Why?
|
| Quality of Life | 1 | 1998 | 946 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1991 | 73 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1992 | 545 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1994 | 475 | 0.010 |
Why?
|